Zobrazeno 1 - 10
of 86
pro vyhledávání: '"Shou-Hua Li"'
Publikováno v:
Chinese Journal of Contemporary Neurology and Neurosurgery, Vol 14, Iss 1, Pp 60-63 (2014)
doi:10.3969/j.issn.1672-6731.2014.01.014
Externí odkaz:
https://doaj.org/article/22184196abb7469f974467f98f00242a
Autor:
Bankole A Johnson, Ahmed M Elkashef, Nassima Ait-Daoud, Chamindi Seneviratne, Roberta C Kahn, Shou-Hua Li, Daniel A Bloch, Tyson H Holmes, Xin-Qun Wang, Ming D Li, Francis J Vocci, Jr.
Publikováno v:
Frontiers in Psychiatry, Vol 1 (2010)
Early-onset methamphetamine use increases the lifetime prevalence of methamphetamine dependence. An earlier onset of methamphetamine use leads to greater damage to the terminal ends of serotonin neurons, more reduction in serotonin transporter (5-HTT
Externí odkaz:
https://doaj.org/article/7a2bd91334b744d99d1c159e44a8b787
Autor:
Tyson H. Holmes, William Haning, Ann L. Anderson, Christopher Stock, John D. Roache, Gantt P. Galloway, Daniel L. Dickerson, Shou Hua Li, Ahmed Elkashef, Jan Campbell, Nora Chiang, Denka Markova, Roberta Kahn
Publikováno v:
Drug and Alcohol Dependence. 150:170-174
Aim Bupropion was tested for efficacy to achieve methamphetamine (MA) abstinence in dependent, non-daily users. Methods A randomized, double-blind, placebo-controlled trial, with 12-week treatment and 4-week follow-up, was conducted with 204 treatmen
Autor:
Alison Swaims-Kohlmeier, A. Santos, J.F. Li, J.T. Lipscomb, Shou-Hua Li, Albert M. Anderson, K.A. Curtis, James G. Johnson
Publikováno v:
Journal of Virus Eradication, Vol 3, Iss, Pp 42-43 (2017)
Autor:
Louis R. Cantilena, Shou-Hua Li, Ann L. Anderson, Roberta Kahn, Connie C. Duncan, Ahmed Elkashef
Publikováno v:
Journal of Addiction Medicine. 6:265-273
OBJECTIVES Atomoxetine has been considered as an agonist replacement therapy for cocaine. We investigated the safety of the interaction of atomoxetine with cocaine and also whether cognitive function was affected by atomoxetine during short-term admi
The design of pharmacological trials for management of substance use disorders is shifting toward outcomes of successful individual-level behavior (abstinence or no heavy use). While binary success/failure analyses are common, McCann and Li (CNS Neur
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::56cfe8c01b3e339ed8e92cf2602e12db
https://europepmc.org/articles/PMC6690342/
https://europepmc.org/articles/PMC6690342/
Autor:
Tracey Serpi, Jan Campbell, David J. Weiss, Richard A. Rawson, Mark Hrymoc, Ruth Dickinson, Barry S. Carlton, Erin Iturriaga, Michael McCann, Nassima Ait-Daoud, Shou-Hua Li, Christopher Stock, Frances McSherry, Bankole A. Johnson, Elmer Yu, Dennis Weis, Tony Pham, Joseph Mawhinney, Ming D. Li, Nora Chiang, Ann L. Anderson, Ahmed Elkashef, William Haning, Charles Gorodetzky, Roberta Kahn
Publikováno v:
Addiction. 107:1297-1306
Aims Topiramate has shown efficacy at facilitating abstinence from alcohol and cocaine abuse. This double-blind, placebo-controlled out-patient trial tested topiramate for treating methamphetamine addiction. Design Participants (n = 140) were randomi
Autor:
David J. McCann, Shou‐Hua Li
Publikováno v:
CNS Neuroscience & Therapeutics. 18:414-418
A multisite, double‐blind, placebo‐controlled trial of bupropion for methamphetamine dependence was reanalyzed using a novel, nonbinary method of evaluating success and failure. The original analysis focused on a group response endpoint (the chan
Autor:
Harold C. Urschel, Ahmed Elkashef, Roberta Kahn, Tyson H. Holmes, Eugene Somoza, Domenic A. Ciraulo, Ann L. Anderson, Shou Hua Li, Nora Chiang, Ihsan M. Salloum, Charles A. Dackis, Edwina V. Smith, John D. Roache, April Slee, Malcolm S. Reid, Lynn Shemanski, Frank Vocci
Publikováno v:
Drug and Alcohol Dependence. 104:133-139
Modafinil was tested for efficacy in facilitating abstinence in cocaine-dependent patients, compared to placebo.This was a double-blind placebo-controlled study, with 12 weeks of treatment and a 4-week follow-up. Six outpatient substance abuse treatm
Autor:
Nora Chiang, Eugene Somoza, Paul S. Horn, Shou-Hua Li, Daniel F. Lewis, Frank Vocci, Theresa Winhusen, Ahmed Elkashef, Peggy Somoza
Publikováno v:
Drug and Alcohol Dependence. 93:132-140
Background There is currently no FDA-approved medication for cocaine dependence and no standard primary outcome measure for reduction of cocaine use in cocaine-dependence trials. The ability to detect a significant medication effect will depend, in p